Study of dispersible TB preventive treatment for children
Part of Infections clinical trials.
This study looks at a new, easier-to-take version of TB preventive medicine (called 3HP) given as a dispersible pill for children. It aims to see how well it works in real clinics and to understand experiences from caregivers, healthcare workers, and policy makers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child must be under 12 years old.
- The child must either be living with HIV or be a household contact of someone with TB in the lungs.
- The child cannot have drug-resistant TB, TB disease, or be on TB treatment now.
- If you are a caregiver, you must be at least 18 years old and willing to be interviewed and audio-recorded.
- If you are a healthcare worker, you see children in a clinic that takes part in this study.
- If you are a policy maker or program manager, you work with programs for HIV, TB, or children's health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a community-friendly way to deliver TB prevention medicine (called TPT) to people's homes in Kenya. Researchers want to see if bringing screening and treatment to your house—instead of making you go to a clinic—helps more people start and finish TB prevention, which can reduce TB spread in your community.
This study is testing a new way to diagnose TB in children using simple symptom checklists. It aims to see if these checklists can help doctors find TB earlier and more accurately, especially in children who are very young or have other health problems.
This trial helps children with tuberculosis (TB) by making sure they get the right care. It aims to see if better support can improve their treatment and recovery.
This trial tests a TB screening method to help more pregnant women with HIV get preventive treatment. It aims to find and treat hidden TB early, keeping both mom and baby safer.
This trial tests whether providing tuberculosis preventive treatment at home, instead of at a clinic, can help protect children under 15 who live with an adult who has recently been diagnosed with pulmonary TB. The goal is to make it easier for families to access care and stop TB from spreading.
This study tests a daily combination of two medicines, rifapentine and isoniazid (called 1HP), to prevent tuberculosis (TB) in children under 13 years old. It includes children who have been exposed to TB or are at high risk, both those living with HIV and those without HIV.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.